https://medicaldialogues.in/news/industry/pharma/nirsevimab-delivers-83-percent-reduction-in-rsv-infant-hospitalizations-in-a-real-world-clinical-trial-setting-sanofi-111421
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi